======= LRRC63 ======= == Gene Information == * **Official Symbol**: LRRC63 * **Official Name**: leucine rich repeat containing 63 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=220416|220416]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q05C16|Q05C16]] * **Interactions**: [[https://thebiogrid.org/search.php?search=LRRC63&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20LRRC63|Open PubMed]] * **OMIM**: N/A == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A |LRR 4| No GO term information is available for this gene. \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp134|MS023 2μM R03 exp134]]|-3.09| |[[:results:exp121|Golgicide-A 2μM R03 exp121]]|-2.01| |[[:results:exp180|Dynasore 10μM R04 exp180]]|-1.96| |[[:results:exp533|TNF-alpha 44ng/ml R08 exp533]]|-1.94| |[[:results:exp376|Losmapimod 1μM R07 exp376]]|-1.76| |[[:results:exp18|Doxycycline 10μM R00 exp18]]|-1.72| |[[:results:exp423|Zebularine 20μM R07 exp423]]|1.71| |[[:results:exp28|Pimelic-diphenylamide-106 5μM R00 exp28]]|1.72| |[[:results:exp466|Cannabidiol 20μM R08 exp466]]|1.74| |[[:results:exp299|Talazoparib 0.006μM R06 exp299]]|1.74| |[[:results:exp493|IL-3 9ng/ml R08 exp493]]|1.75| |[[:results:exp8|Brefeldin A 0.02μM R00 exp8]]|1.79| |[[:results:exp348|Cyclosporin-A 3μM R07 exp348]]|1.79| |[[:results:exp329|Hydroxyurea 100μM R07 exp329]]|1.81| |[[:results:exp525|Sulforaphane 9μM R08 exp525]]|1.81| |[[:results:exp344|Chlorpromazine 10μM R07 exp344]]|1.82| |[[:results:exp501|Methotrexate 0.01μM R08 exp501]]|1.97| |[[:results:exp281|Disulfiram 4.3μM R06 exp281]]|1.98| |[[:results:exp256|HMS-I1 10μM R06 exp256]]|1.98| |[[:results:exp534|Trientine 500μM R08 exp534]]|2| |[[:results:exp426|FBS-Wisent 0.1 R07 exp426]]|2| |[[:results:exp316|Geldanamycin 0.015 to 0.025μM on day4 R07 exp316]]|2.03| |[[:results:exp294|Nutlin-3A 1.6μM R06 exp294]]|2.05| |[[:results:exp409|THZ531 0.11μM R07 exp409]]|2.08| |[[:results:exp392|PT-1 25μM R07 exp392]]|2.19| |[[:results:exp499|LY2090314 0.003μM R08 exp499]]|2.21| |[[:results:exp512|Olaparib 4μM R08 exp512]]|2.21| |[[:results:exp422|Wiskostatin 3μM R07 exp422]]|2.24| |[[:results:exp269|Bisphenol A 100μM R06 exp269]]|2.27| |[[:results:exp359|FK-506 30μM R07 exp359]]|2.28| |[[:results:exp410|THZ531 0.11 to 0.125μM on day4 R07 exp410]]|2.28| |[[:results:exp301|VER-155008 3.9μM R06 exp301]]|2.51| |[[:results:exp365|I-BRD9 4μM R07 exp365]]|2.67| |[[:results:exp331|A-769662 20μM R07 exp331]]|2.82| |[[:results:exp447|Amiloride 100μM R08 exp447]]|3.01| |[[:results:exp275|Citral 75μM R06 exp275]]|3.37| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 14989 * **Expression level (log2 read counts)**: -0.15 {{:chemogenomics:nalm6 dist.png?nolink |}}